Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00613145
Recruitment Status : Completed
First Posted : February 12, 2008
Last Update Posted : February 4, 2013
Information provided by (Responsible Party):
SCRI Development Innovations, LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2009
  Study Completion Date : May 2010